Reports for TARO PHARMACEUTICALS INC
Company Name
TARO PHARMACEUTICALS INC
Totals |
||
Shortage reports |
503 |
|
| Actual shortage: | 26 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 477 (95%) | |
Discontinuation Reports |
17 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 17 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
267 (51%) |
|
Overdue reports |
14 (54%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-DICLOFENAC | 1.5% | SOLUTION | Resolved | 2023-08-18 | 2023-10-25 | 202456 |
| TARO-TESTOSTERONE CYPIONATE INJECTION | 100MG | SOLUTION | Resolved | 2022-11-04 | 2023-02-28 | 173707 |
| TARO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2021-10-13 | 2021-11-26 | 147104 |
| TARO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2022-08-25 | 2023-02-11 | 167877 |
| TARO-PHENYTOIN | 125MG | SUSPENSION | Resolved | 2018-08-03 | 2018-10-16 | 57525 |
| TARO-PHENYTOIN | 125MG | SUSPENSION | Resolved | 2019-08-23 | 2019-10-12 | 92417 |
| TARO-PHENYTOIN | 125MG | SUSPENSION | Resolved | 2019-11-01 | 2019-11-26 | 97853 |
| TARO-PHENYTOIN | 125MG | SUSPENSION | Resolved | 2021-06-16 | 2021-07-13 | 141000 |
| TARO-PHENYTOIN | 125MG | SUSPENSION | Resolved | 2022-11-04 | 2022-11-15 | 173742 |
| TARO-PHENYTOIN | 125MG | SUSPENSION | Resolved | 2023-08-18 | 2023-10-25 | 202476 |
| TARO-CARBAMAZEPINE | 100MG | SUSPENSION | Resolved | 2017-09-18 | 2019-02-04 | 22252 |
| TARO-CARBAMAZEPINE | 100MG | SUSPENSION | Resolved | 2019-09-03 | 2019-10-21 | 92819 |
| TARO-CARBAMAZEPINE | 100MG | SUSPENSION | Resolved | 2019-11-01 | 2020-01-20 | 97844 |
| TARO-CARBAMAZEPINE | 100MG | SUSPENSION | Resolved | 2020-07-28 | 2020-10-07 | 121200 |
| TARO-CARBAMAZEPINE | 100MG | SUSPENSION | Resolved | 2021-07-13 | 2021-07-19 | 142437 |
| TARO-CARBAMAZEPINE | 100MG | SUSPENSION | Resolved | 2021-12-07 | 2022-08-25 | 150620 |
| TARO-CARBAMAZEPINE | 100MG | SUSPENSION | Resolved | 2024-01-05 | 2024-02-08 | 215076 |
| TARO-DOXORUBICIN LIPOSOMAL | 2MG | SUSPENSION | Resolved | 2022-11-04 | 2023-01-19 | 173730 |
| TARO-BUDESONIDE | 0.125MG | SUSPENSION | Actual shortage | 2022-11-03 | 2024-01-05 | 173505 |
| TARO-BUDESONIDE | 0.25MG | SUSPENSION | Actual shortage | 2022-11-03 | 2024-01-05 | 173508 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-TEMOZOLOMIDE | 5MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123252 |
| TARO-TEMOZOLOMIDE | 20MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123255 |
| TARO-TEMOZOLOMIDE | 100MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123258 |
| TARO-AMCINONIDE | 0.1% | CREAM | Discontinued | 2020-05-14 | 2020-05-14 | 115031 |
| MICOZOLE | 2% | CREAM | Discontinued | 2022-11-04 | 2022-11-04 | 173736 |
| VIADERM KC ONT | 1MG 100000UNIT 0.25MG 2.5MG | OINTMENT | Discontinued | 2019-08-09 | 2019-08-10 | 91315 |
| TARO-WARFARIN | 10MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80067 |
| TARO-WARFARIN | 2.5MG | TABLET | Discontinued | 2019-11-01 | 2019-11-02 | 97862 |
| TARO-WARFARIN | 2MG | TABLET | Discontinued | 2021-08-24 | 2021-08-24 | 144558 |
| TARO-WARFARIN | 2.5MG | TABLET | Discontinued | 2021-11-26 | 2021-11-26 | 150094 |
| TARO-WARFARIN | 3MG | TABLET | Discontinued | 2021-11-26 | 2021-11-26 | 150097 |
| TARO-WARFARIN | 5MG | TABLET | Discontinued | 2021-12-07 | 2021-12-07 | 150693 |
| TARO-WARFARIN | 7.5MG | TABLET | Discontinued | 2022-11-04 | 2022-11-04 | 173760 |
| TARO-WARFARIN | 5MG | TABLET | Discontinued | 2023-09-25 | 2023-09-25 | 205189 |
| TARO-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105030 |
| TARO-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105033 |
| TARO-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105036 |
Showing 1 to 17 of 17